Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning balance at Jan. 31, 2021 $ 31,541 $ 378 $ 246,446 $ (227) $ (73) $ (214,983)
Beginning balance, shares at Jan. 31, 2021   37,811,224        
Issuance of common stock pursuant to vesting of stock units   $ 11 (11)      
Issuance of common stock pursuant to vesting of stock units, shares   1,100,691        
Issuance of common stock pursuant to exercise of stock options 161 $ 1 160      
Issuance of common stock pursuant to exercise of stock options, shares   112,205        
Issuance of common stock, net of issuance costs 17,462 $ 103 17,359      
Issuance of common stock, net of issuance costs, shares   10,323,484        
Stock-based compensation expense 1,690   1,690      
Unrealized gains (losses) on marketable securities 1       1  
Foreign currency translation adjustments (901)       (901)  
Net loss (7,430)         (7,430)
Ending balance at Jan. 31, 2022 42,524 $ 493 265,644 (227) (973) (222,413)
Ending balance, shares at Jan. 31, 2022   49,347,604        
Issuance of common stock pursuant to vesting of stock units   $ 10 (10)      
Issuance of common stock pursuant to vesting of stock units, shares   1,038,774        
Stock-based compensation expense 1,001   1,001      
Unrealized gains (losses) on marketable securities (25)       (25)  
Foreign currency translation adjustments (892)       (892)  
Short swing profit settlement 7   7      
Net loss (11,404)         (11,404)
Ending balance at Jan. 31, 2023 $ 31,211 $ 503 $ 266,642 $ (227) $ (1,890) $ (233,817)
Ending balance, shares at Jan. 31, 2023   50,386,378